Julianna Bruzzese
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Julianna Bruzzese has a total of 15 co-authors. Here are the top co-authors by number of shared publications:
Alex Wu
Department of Genetics, Rutgers University, Piscataway, NJ, USA
1 shared publication- Ansu O. Perekatt
Department of Chemistry and Chemical Biology, Stevens Institute of Technology
1 shared publication Cindy Lin
Department of Chemistry and Chemical Biology, Stevens Institute of Technology
1 shared publicationConnor Mills
Department of Chemistry and Chemical Biology, Stevens Institute of Technology
1 shared publicationCrystal Lim
Department of Chemistry and Chemical Biology, Stevens Institute of Technology
1 shared publicationDahlia Matouba
Department of Chemistry and Chemical Biology, Stevens Institute of Technology
1 shared publication
Latest Publications
- Open Access
- 4 October 2024
- Published by Life Science Alliance, LLC in Life Science Alliance
- Vol. 7 (12) , e202402935
Epithelial-specific loss of Smad4 alleviates the fibrotic response in an acute colitis mouse model
Mucosal healing is associated with better clinical outcomes in patients with inflammatory bowel disease. But the epithelial-specific contribution to mucosal healing in vivo is poorly understood. We evaluated mucosal healing in an acute dextran sulfate sodium mouse model that shows an alleviated colitis response after epithelial-specific loss of Smad4. We find that enhanced epithelial wound healing alleviates the fibrotic response. Dextran sulfate sodium caused increased mesenchymal collagen deposition—indicative of fibrosis—within a week in the WT but not in the Smad4 KO colon. The fibrotic response correlated with decreased epithelial proliferation in the WT, whereas uninterrupted proliferation and an expanded zone of proliferation were observed in the Smad4 KO colon epithelium. Furthermore, the Smad4 KO colon showed epithelial extracellular matrix alterations that promote epithelial regeneration. Our data suggest that epithelium is a key determinant of the mucosal healing response in vivo, implicating mucosal healing as a strategy against fibrosis in inflammatory bowel disease patients.
- 4 October 2024
- Published by Life Science Alliance, LLC in Life Science Alliance
- Vol. 7 (12) , e202402935
Open AccessEpithelial-specific loss of Smad4 alleviates the fibrotic response in an acute colitis mouse model
Mucosal healing is associated with better clinical outcomes in patients with inflammatory bowel disease. But the epithelial-specific contribution to mucosal healing in vivo is poorly understood. We evaluated mucosal healing in an acute dextran sulfate sodium mouse model that shows an alleviated colitis response after epithelial-specific loss of Smad4. We find that enhanced epithelial wound healing alleviates the fibrotic response. Dextran sulfate sodium caused increased mesenchymal collagen deposition—indicative of fibrosis—within a week in the WT but not in the Smad4 KO colon. The fibrotic response correlated with decreased epithelial proliferation in the WT, whereas uninterrupted proliferation and an expanded zone of proliferation were observed in the Smad4 KO colon epithelium. Furthermore, the Smad4 KO colon showed epithelial extracellular matrix alterations that promote epithelial regeneration. Our data suggest that epithelium is a key determinant of the mucosal healing response in vivo, implicating mucosal healing as a strategy against fibrosis in inflammatory bowel disease patients.